Progesterone receptor variants found in breast cells repress transcription by wild-type receptors

Breast Cancer Research and Treatment

Volumn 48, Issue 3, 1998, Pages 231-241

  Richer, J K ^a   Lange, C A ^a   Wierman, A M ^a   Brooks, K M ^a   Tung, L ^a   Takimoto, G S ^a   Horwitz, K B ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Dominant negative variants; Hormone dependence; Markers; Progesterone receptors; Splice variants

Indexed keywords

CELL NUCLEUS RECEPTOR; MESSENGER RNA; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; BREAST CELL; CANCER GROWTH; CELL LINE; CELL STRAIN MCF 7; CONTROLLED STUDY; EXON; HORMONE DEPENDENCE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROGNOSIS; TRANSCRIPTION REGULATION;

BREAST; BREAST NEOPLASMS; DRUG RESISTANCE; EXONS; FEMALE; HUMANS; PROGESTINS; RECEPTORS, PROGESTERONE; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0031947298     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005941117247     Document Type: Article

References (45)

1. Clarke CL, Sutherland RL: Progestin regulation of cellular proliferation. Endocr Rev 11: 266-302, 1990
2. Horwitz KB: The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer? Endocr Rev 13: 146-163, 1992
3. Horwitz KB, McGuire WL, Pearson OH, Segaloff A: Predicting response to endocrine therapy in human breast cancer: a hypothesis. Science 189: 726-727, 1975
4. Clark GM, McGuire WL, Hubay CA: Progesterone receptors as a prognstic factor in stage II breast cancer. N Engl J Med 309: 1343-1347, 1983
5. Ponglikitmongkol M, Green S, Chambon P: Genomic organization of the human oestrogen receptor gene. EMBO J 7: 3383-3388, 1988
6. Fuqua SAW, Fitzgerald SD, Chamness GC, Tandon AK, McDonnell DP, Nawaz Z, O'Malley BW, McGuire WL: Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res 51: 105-109, 1991
7. Koehorst SGA, Jacobs HM, Tilanus MGJ, Bowens AGM, Thijssen JHH, Blankenstein MA: Aberrant oestrogen receptor species in human meningioma tissue. J Steroid Biochem Mol Biol 43: 57-61, 1992
8. Skipper JK, Young LJ, Bergeron JM, Tetzlaff MT, Osborn CT, Crews D: Identification of an isoform of oestrogen receptor mRNA lacking exon four and present in the brain. Proc Natl Acad Sci USA 90: 7172-7175, 1993
9. Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J: Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93: 5925-5930, 1996
10. Pfeffer U, Fecarotta E, Vivaldi G: Coexpression of multiple estrogen receptor variant messenger RNAs in normal and neoplastic breast tissues and in MCF-7 cells. Cancer Res 55: 2158-2165, 1995
11. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS: Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331: 1056-1061, 1994
12. Wilson CM, McPhaul MJ: A and B forms of the androgen receptor are present in human genital skin fibroblasts. Proc Natl Acad Sci USA 91: 1234-1238, 1994
13. Brown TR, Lubahn DB, Wilson EM, Joseph DR, French FS, Migeon CJ: Deletion of the steroid binding domain of the human androgen receptor gene in one family with complete androgen insensitivity syndrome: Evidence for further genetic heterogeneity in this syndrome. Proc Natl Acad Sci USA 85: 8151-8155, 1988
14. Toplin ME, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK, Keer HN, Balk SP: Mutation of the androgen receptor gene in metabolic androgen-independent prostate cancer. N Engl J Med 332: 1393-1398, 1995
15. Bamberger CM, Bamberger AM, deCastro M, Chrousos GP: Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 95: 2435-2441, 1995
16. Ashraf J, Thompson EB: Identification of the activation-labile gene: A single point mutation in the human glucocorticoid receptor presents as two distinct receptor phenotypes. Mol Endocrinol 7: 631-642, 1993
17. Kastner P, Mark M, Chambon P: Nonsteroid nuclear receptors: What are genetic studies telling us about their role in real life? Cell 83: 859-869, 1995
18. Sakurai A, Takeda K, Ain K, Ceccarelli P, Nakai A, Seino S, Bell GI, Refetoff S, DeGroot LJ: Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid receptor β. Proc Natl Acad Sci USA 86: 8977-8981, 1989
19. Usala SJ, Tennyon GE, Bole AE, Lash RW, Gesundheit N, Wondisford EE, Accili D, Hauser P, Weintraub BD: A base mutation of the c-erbAβ thyroid hormone receptor in a kindred with thyroid hormone resistance. Molecular heterogeneity in two other kindreds. J Clin Invest 85: 93-100, 1990
20. Horwitz KB, Alexander PS: In situ photolinked nuclear progesterone receptors of human breast cancer cells: Subunit molecular weights after transformation and translocation. Endocrinology 113: 2195-2201, 1983
21. Wei LL, Gonzalez-Aller C, Wood WM, Horwitz KB: 5′-heterogeneity in human progesterone receptor transcripts predicts a new amino-terminal truncated 'C'-receptor and unique A-receptor messages. Mol Endocrinol 4: 1833-1840, 1990
22. Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P: Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 9: 1603-1614, 1990
23. Spelsberg TC, Halberg F: Circannual rhythms in steroid concentration and nuclear binding in the chick oviduct. Endocrinology 107: 1234-1244, 1980
24. Boyd-Leinen FA, Fournier D, Thomas CS: Nonfunctioning progesterone receptors in the developed oviducts from estrogen-withdrawn immature chicks and in aged nonlaying hens. Endocrinology 111: 30-36, 1982
25. Kalo J, Hirata S, Nozawa A, Mouri N: The ontogeny of gene expression of progestin receptors in the female rat brain. J Steroid Biochem Mol Biol 47: 173-182, 1993
26. Sartorius CA, Groshong SD, Miller LA, Powell RP, Tung L, Takimoto GS, Horwitz KB: New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: Only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP. Cancer Res 54: 3868-3877, 1994
27. Sartorius CA, Melville MY, Hovland AR, Tung L, Takimoto GS, Horwitz KB: A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform. Mol Endocrinol 8: 1347-1360, 1994
28. Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O'Malley BW, McDonnell DP: Human progesterone receptor A form is a cell and promoter specific repressor of human progesterone receptor B function. Mol Endocrinol 7: 1244-1255, 1993
29. Sartorius CA, Tung L, Takimoto GS, Horwitz KB: Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP. J Biol Chem 5: 9262-9266, 1993
30. Wei LL, Miner R: Evidence for the existence of a third progesterone receptor protein in human breast cancer cell line T47D. Cancer Res 54: 340-343, 1994
31. Graham JD, Yeates C, Balleine RL, Harvey SS, Milliken JS, Bilous AM, Clarke CL: Characterisation of progesterone receptor A and B expression in human breast cancer. Cancer Res 55: 5063-5068, 1995
32. Misrahi M, Atger M, d'Auriol L, Loosfelt H, Meriel C, Fridlansky F, Guiochon-Mantel A, Galibert F, Milgrom E: Complete amino acid sequence of the human progesterone receptor deduced from cloned DNA. Biochem Biophys Res Commun 143: 740-748, 1987
33. Sun-Yu N, Gunning P, Eddy R, Ponte P, Leavitt J, Shows T, Kedes L: Evolution of the functional human β-actin gene and its multi-pseudogene family: Conservation of noncoding regions and chromosomal dispersion of pseudogenes. Mol Cell Biol 5: 2720-2732, 1985
34. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98: 503-517, 1975
35. Kastner P, Bocquel MT, Turcotte B, Gamier JM, Horwitz KB, Chambon P, Gronemeyer H: Transient expression of human and chicken progesterone receptors does not support alternative translational initiation from a single mRNA as the mechanism generating two receptor isoforms. J Biol Chem 265: 12163-12167, 1990
36. Lange-Carter CA, Johnson GL: Assay of MEK kinases. Meth Enzymol 255: 290-301, 1995
37. Tora L, Mullick A, Metzger D, Ponglikitmongkol M, Park I, Chambon P: The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. EMBO J 8: 1981-1986, 1989
38. Madsen MW, Reiter BE, Lykkesfeldt AE: Differential expression of estrogen receptor mRNA splice variants in the tamoxifen resistant human breast cancer cell line. MCF-7/ TAMR-1 compared to the parental MCF-7 cell line. Mol Cell Endocrinol 109: 197-207, 1995
39. Truss M, Beato M: Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endoer Rev 14: 459-479, 1995
40. Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L: Nuclear receptor coactivators and corepressors. Mol Endocrinol 10: 1167-1177, 1996
41. Leygue E, Dotzlaw H, Watson PH, Murphy LC: Identification of novel exon-deleted progesterone receptor variant mRNAs in human breast tissue. Biochem Biophys Res Commun 228: 63-68, 1996
42. McGuire WL, Clark GM, Dressier LG, Owens MA: Role of steroid hormone receptors as prognostic factors in primary breast cancer. NCI Monogr 1: 19-23, 1986
43. Sedlacek SM, Horwitz KB: The role of progestins and progesterone receptors in the treatment of breast cancer. Steroids 44: 467-484, 1984
44. Fitzgerald PA: Handbook of Clinical Endocrinology. Prentice Hall, Englewood Cliffs, NJ, 1992
45. Horwitz KB: Editorial: When tamoxifen turns bad. Endocrinology 136: 821-823, 1995